Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
47
SHTDF Quote, Financials, Valuation and Earnings
Last price:
$2.68
Seasonality move
:
-5.61%
Day range:
$2.68 - $2.68
52-week range:
$2.11 - $2.70
Dividend yield:
3.52%
P/E ratio:
8.38x
P/S ratio:
0.10x
P/B ratio:
0.69x
Volume:
--
Avg. volume:
73
1-year change:
24.42%
Market cap:
$8.3B
Revenue:
$80B
EPS (TTM):
$0.32
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Sinopharm Group Co., Ltd. has -- downside to fair value with a price target of -- per share.
SHTDF vs. S&P 500
-
Over the past 5 trading days, Sinopharm Group Co., Ltd. has underperformed the S&P 500 by -3.25% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sinopharm Group Co., Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sinopharm Group Co., Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Sinopharm Group Co., Ltd. reported revenues of $20.6B.
Earnings Growth
-
Sinopharm Group Co., Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Sinopharm Group Co., Ltd. reported earnings per share of $0.07.
Enterprise value:
16.4B
EV / Invested capital:
--
Price / LTM sales:
0.10x
EV / EBIT:
7.04x
EV / Revenue:
0.20x
PEG ratio (5yr expected):
--
EV / Free cash flow:
12.32x
Price / Operating cash flow:
32.59x
Enterprise value / EBITDA:
5.49x
Gross Profit (TTM):
$5.7B
Return On Assets:
1.76%
Net Income Margin (TTM):
1.88%
Return On Equity:
5.75%
Return On Invested Capital:
3.51%
Operating Margin:
3.78%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $20B | $20.6B | |
| Gross Profit | -- | -- | -- | -- | $1.6B | |
| Operating Income | -- | -- | -- | -- | $780M | |
| EBITDA | -- | -- | -- | -- | $474.6M | |
| Diluted EPS | -- | -- | -- | -- | $0.07 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $45.6B | $46.3B | $47.5B | $47.6B | -- | |
| Total Assets | $52.6B | $52.9B | $54.1B | $53.8B | -- | |
| Current Liabilities | $34.4B | $34.1B | $34.1B | $34.3B | -- | |
| Total Liabilities | $37B | $36.9B | $37.1B | $36.5B | -- | |
| Total Equity | $15.6B | $16B | $17B | $17.4B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$8.6M | |
| Cash From Financing | -- | -- | -- | -- | $2.8B | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SHTDF
Sector
Market Cap
$8.3B
$23.9M
Price % of 52-Week High
99.07%
47.44%
Dividend Yield
3.52%
0%
Shareholder Yield
3.62%
-1.9%
1-Year Price Total Return
24.42%
-18.29%
Beta (5-Year)
-0.051
0.513
Dividend yield:
3.52%
Annualized payout:
$0.09
Payout ratio:
-27.69%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.68
200-day SMA
Buy
Level
$2.43
Bollinger Bands (100)
Buy
Level
2.41 - 2.65
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$2.65
Relative Strength Index (RSI14)
Buy
Level
73.25
ADX Line
Buy
Level
48.67
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$2.55
MACD (12, 26)
Buy
Level
0.70
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
200
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2205)
Sell
CA Score
(Annual)
Level (-1.0414)
Buy
Beneish M-Score
(Annual)
Level (-2.4037)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.534)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
Stock Forecast FAQ
In the current month, SHTDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SHTDF average analyst price target in the past 3 months is --.
-
Where Will Sinopharm Group Co., Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sinopharm Group Co., Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sinopharm Group Co., Ltd.?
Analysts are divided on their view about Sinopharm Group Co., Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sinopharm Group Co., Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Sinopharm Group Co., Ltd.'s Price Target?
The price target for Sinopharm Group Co., Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SHTDF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sinopharm Group Co., Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SHTDF?
You can purchase shares of Sinopharm Group Co., Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sinopharm Group Co., Ltd. shares.
-
What Is The Sinopharm Group Co., Ltd. Share Price Today?
Sinopharm Group Co., Ltd. was last trading at $2.68 per share. This represents the most recent stock quote for Sinopharm Group Co., Ltd.. Yesterday, Sinopharm Group Co., Ltd. closed at $2.68 per share.
-
How To Buy Sinopharm Group Co., Ltd. Stock Online?
In order to purchase Sinopharm Group Co., Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SHTDF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHTDF
Sector
P/E ratio
8.38x
21.37x
PEG ratio
--
-0.01x
P/B ratio
0.69x
1.72x
Price / LTM sales
0.10x
1.44x
Growth Metrics
SHTDF
Sector
Revenue growth
--
3.44%
Earnings growth
--
14.97%
Revenue (5-year growth)
3.89%
6.27%
Earnings forecast
--
-$0.22
Profitability
SHTDF
Sector
Profitability FY 2025
$5.7B
$2.4M
Return on invested capital
3.51%
-33.43%
Return on assets
1.76%
-29.45%
Return on equity
5.75%
-40.29%
Earnings Date
Last Earnings Date
Oct
27
Next Earnings Date
Apr
23
Estimated Next Earnings Date
Jan
26
Balance Sheet
SHTDF
Sector
Total cash
$7.4B
$25.6M
Short term investments
$21.6K
$22.7M
Total assets
$55.9B
$70.4M
Long term debt
--
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
